Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 239

1.

Community analysis and co-occurrence patterns in airway microbial communities during health and disease.

Einarsson GG, Zhao J, LiPuma JJ, Downey DG, Tunney MM, Elborn JS.

ERJ Open Res. 2019 Jul 8;5(3). pii: 00128-2017. doi: 10.1183/23120541.00128-2017. eCollection 2019 Jul.

2.

Retrospective Analysis of Nontuberculous Mycobacterial Infection and Monochloramine Disinfection of Municipal Drinking Water in Michigan.

Kotlarz N, Raskin L, Zimbric M, Errickson J, LiPuma JJ, Caverly LJ.

mSphere. 2019 Jul 3;4(4). pii: e00160-19. doi: 10.1128/mSphere.00160-19.

3.

Population Structure, Molecular Epidemiology, and β-Lactamase Diversity among Stenotrophomonas maltophilia Isolates in the United States.

Mojica MF, Rutter JD, Taracila M, Abriata LA, Fouts DE, Papp-Wallace KM, Walsh TJ, LiPuma JJ, Vila AJ, Bonomo RA.

MBio. 2019 Jul 2;10(4). pii: e00405-19. doi: 10.1128/mBio.00405-19.

4.

"Switching partners": Piperacillin-avibactam is a highly potent combination against multidrug-resistant Burkholderia cepacia Complex and Burkholderia gladioli Cystic Fibrosis isolates.

Zeiser ET, Becka SA, Wilson BM, Barnes MD, LiPuma JJ, Papp-Wallace KM.

J Clin Microbiol. 2019 Jun 5. pii: JCM.00181-19. doi: 10.1128/JCM.00181-19. [Epub ahead of print]

PMID:
31167848
5.

Stenotrophomonas maltophilia Differential Gene Expression in Synthetic Cystic Fibrosis Sputum Reveals Shared and Cystic Fibrosis Strain-Specific Responses to the Sputum Environment.

Willsey GG, Eckstrom K, LaBauve AE, Hinkel LA, Schutz K, Meagher RJ, LiPuma JJ, Wargo MJ.

J Bacteriol. 2019 Jul 10;201(15). pii: e00074-19. doi: 10.1128/JB.00074-19. Print 2019 Aug 1.

PMID:
31109991
6.

Reconciling Antimicrobial Susceptibility Testing and Clinical Response in Antimicrobial Treatment of Chronic Cystic Fibrosis Lung Infections.

Waters VJ, Kidd TJ, Canton R, Ekkelenkamp MB, Johansen HK, LiPuma JJ, Bell SC, Elborn JS, Flume PA, VanDevanter DR, Gilligan P; Antimicrobial Resistance International Working Group in Cystic Fibrosis.

Clin Infect Dis. 2019 May 6. pii: ciz364. doi: 10.1093/cid/ciz364. [Epub ahead of print]

PMID:
31056660
7.

Nontuberculous mycobacteria in drinking water systems - the challenges of characterization and risk mitigation.

Dowdell K, Haig SJ, Caverly LJ, Shen Y, LiPuma JJ, Raskin L.

Curr Opin Biotechnol. 2019 Jun;57:127-136. doi: 10.1016/j.copbio.2019.03.010. Epub 2019 Apr 16. Review.

PMID:
31003169
8.

In Vitro Activity of a Novel Glycopolymer against Biofilms of Burkholderia cepacia Complex Cystic Fibrosis Clinical Isolates.

Narayanaswamy VP, Duncan AP, LiPuma JJ, Wiesmann WP, Baker SM, Townsend SM.

Antimicrob Agents Chemother. 2019 May 24;63(6). pii: e00498-19. doi: 10.1128/AAC.00498-19. Print 2019 Jun.

9.

Resurrecting Old β-Lactams: Potent Inhibitory Activity of Temocillin against Multidrug-Resistant Burkholderia Species Isolates from the United States.

Zeiser ET, Becka SA, Barnes MD, Taracila MA, LiPuma JJ, Papp-Wallace KM.

Antimicrob Agents Chemother. 2019 Mar 27;63(4). pii: e02315-18. doi: 10.1128/AAC.02315-18. Print 2019 Apr.

PMID:
30718248
10.

Draft Genome Sequences of Two Cystic Fibrosis Strains of Stenotrophomonas maltophilia, AU30115 and AU32848.

Eckstrom K, Willsey GG, LiPuma JJ, Wargo MJ.

Microbiol Resour Announc. 2018 Sep 20;7(11). pii: e01137-18. doi: 10.1128/MRA.01137-18. eCollection 2018 Sep.

11.

Defining antimicrobial resistance in cystic fibrosis.

Kidd TJ, Canton R, Ekkelenkamp M, Johansen HK, Gilligan P, LiPuma JJ, Bell SC, Elborn JS, Flume PA, VanDevanter DR, Waters VJ; Antimicrobial Resistance in Cystic Fibrosis International Working Group.

J Cyst Fibros. 2018 Nov;17(6):696-704. doi: 10.1016/j.jcf.2018.08.014. Epub 2018 Sep 25. Review.

PMID:
30266518
12.

Successful Lung Re-transplant in a Patient with Cepacia Syndrome due to Burkholderia ambifaria.

Goodlet KJ, Nailor MD, Omar A, Huang JL, LiPuma JJ, Walia R, Tokman S.

J Cyst Fibros. 2019 Jan;18(1):e1-e4. doi: 10.1016/j.jcf.2018.08.011. Epub 2018 Sep 14.

PMID:
30224331
13.

Cystic fibrosis respiratory microbiota: unraveling complexity to inform clinical practice.

Caverly LJ, LiPuma JJ.

Expert Rev Respir Med. 2018 Oct;12(10):857-865. doi: 10.1080/17476348.2018.1513331. Epub 2018 Sep 3. Review.

PMID:
30118374
14.

Burkholderia multivorans septicemia in a pediatric liver transplant patient.

Ho SSC, Nashid N, Waters VJ, LiPuma JJ, Zlosnik JEA, Otley A, Somers GR, Kamath BM, Yau YCW.

Am J Transplant. 2019 Mar;19(3):933-938. doi: 10.1111/ajt.15065. Epub 2018 Sep 5.

PMID:
30091842
15.

Characterization of the AmpC β-Lactamase from Burkholderia multivorans.

Becka SA, Zeiser ET, Barnes MD, Taracila MA, Nguyen K, Singh I, Sutton GG, LiPuma JJ, Fouts DE, Papp-Wallace KM.

Antimicrob Agents Chemother. 2018 Sep 24;62(10). pii: e01140-18. doi: 10.1128/AAC.01140-18. Print 2018 Oct.

16.

Good cop, bad cop: anaerobes in cystic fibrosis airways.

Caverly LJ, LiPuma JJ.

Eur Respir J. 2018 Jul 11;52(1). pii: 1801146. doi: 10.1183/13993003.01146-2018. Print 2018 Jul. No abstract available.

PMID:
29997183
17.

Sequence heterogeneity of the PenA carbapenemase in clinical isolates of Burkholderia multivorans.

Becka SA, Zeiser ET, Marshall SH, Gatta JA, Nguyen K, Singh I, Greco C, Sutton GG, Fouts DE, LiPuma JJ, Papp-Wallace KM.

Diagn Microbiol Infect Dis. 2018 Nov;92(3):253-258. doi: 10.1016/j.diagmicrobio.2018.06.005. Epub 2018 Jun 18.

18.

Fluctuations in airway bacterial communities associated with clinical states and disease stages in cystic fibrosis.

Carmody LA, Caverly LJ, Foster BK, Rogers MAM, Kalikin LM, Simon RH, VanDevanter DR, LiPuma JJ.

PLoS One. 2018 Mar 9;13(3):e0194060. doi: 10.1371/journal.pone.0194060. eCollection 2018.

19.

Genome Sequences of 12 Pseudomonas lundensis Strains Isolated from the Lungs of Humans.

Scales BS, Erb-Downward JR, Falkowski NR, LiPuma JJ, Huffnagle GB.

Genome Announc. 2018 Feb 15;6(7). pii: e01461-17. doi: 10.1128/genomeA.01461-17.

20.
21.

Multistate Outbreak of an Emerging Burkholderia cepacia Complex Strain Associated With Contaminated Oral Liquid Docusate Sodium.

Akinboyo IC, Sick-Samuels AC, Singeltary E, Fackler J, Ascenzi J, Carroll KC, Maldonado Y, Brooks RB, Benowitz I, Wilson LE, LiPuma JJ, Milstone AM.

Infect Control Hosp Epidemiol. 2018 Feb;39(2):237-239. doi: 10.1017/ice.2017.265. No abstract available.

22.

A putative lateral flagella of the cystic fibrosis pathogen Burkholderia dolosa regulates swimming motility and host cytokine production.

Roux D, Schaefers M, Clark BS, Weatherholt M, Renaud D, Scott D, LiPuma JJ, Priebe G, Gerard C, Yoder-Himes DR.

PLoS One. 2018 Jan 18;13(1):e0189810. doi: 10.1371/journal.pone.0189810. eCollection 2018.

23.

A multistate investigation of health care-associated Burkholderia cepacia complex infections related to liquid docusate sodium contamination, January-October 2016.

Glowicz J, Crist M, Gould C, Moulton-Meissner H, Noble-Wang J, de Man TJB, Perry KA, Miller Z, Yang WC, Langille S, Ross J, Garcia B, Kim J, Epson E, Black S, Pacilli M, LiPuma JJ, Fagan R; B. cepacia Investigation Workgroup.

Am J Infect Control. 2018 Jun;46(6):649-655. doi: 10.1016/j.ajic.2017.11.018. Epub 2018 Jan 9.

24.

Biofilms in Full-Scale Drinking Water Ozone Contactors Contribute Viable Bacteria to Ozonated Water.

Kotlarz N, Rockey N, Olson TM, Haig SJ, Sanford L, LiPuma JJ, Raskin L.

Environ Sci Technol. 2018 Mar 6;52(5):2618-2628. doi: 10.1021/acs.est.7b04212. Epub 2018 Feb 13.

PMID:
29299927
25.

Making It Last: Storage Time and Temperature Have Differential Impacts on Metabolite Profiles of Airway Samples from Cystic Fibrosis Patients.

Wandro S, Carmody L, Gallagher T, LiPuma JJ, Whiteson K.

mSystems. 2017 Nov 28;2(6). pii: e00100-17. doi: 10.1128/mSystems.00100-17. eCollection 2017 Nov-Dec.

26.

Avibactam Restores the Susceptibility of Clinical Isolates of Stenotrophomonas maltophilia to Aztreonam.

Mojica MF, Papp-Wallace KM, Taracila MA, Barnes MD, Rutter JD, Jacobs MR, LiPuma JJ, Walsh TJ, Vila AJ, Bonomo RA.

Antimicrob Agents Chemother. 2017 Sep 22;61(10). pii: e00777-17. doi: 10.1128/AAC.00777-17. Print 2017 Oct.

27.

In Vitro Activity of Ceftolozane-Tazobactam and Other Antimicrobial Agents against Burkholderia cepacia Complex and Burkholderia gladioli.

Mazer DM, Young C, Kalikin LM, Spilker T, LiPuma JJ.

Antimicrob Agents Chemother. 2017 Aug 24;61(9). pii: e00766-17. doi: 10.1128/AAC.00766-17. Print 2017 Sep.

28.

Novel glycopolymer sensitizes Burkholderia cepacia complex isolates from cystic fibrosis patients to tobramycin and meropenem.

Narayanaswamy VP, Giatpaiboon S, Baker SM, Wiesmann WP, LiPuma JJ, Townsend SM.

PLoS One. 2017 Jun 29;12(6):e0179776. doi: 10.1371/journal.pone.0179776. eCollection 2017.

29.

Ecological networking of cystic fibrosis lung infections.

Quinn RA, Whiteson K, Lim YW, Zhao J, Conrad D, LiPuma JJ, Rohwer F, Widder S.

NPJ Biofilms Microbiomes. 2016 Dec 2;2:4. doi: 10.1038/s41522-016-0002-1. eCollection 2016.

30.

Nanoemulsion is an effective antimicrobial for methicillin-resistant Staphylococcus aureus in infected wounds.

Cao Z, Spilker T, Fan Y, Kalikin LM, Ciotti S, LiPuma JJ, Makidon PE, Wilkinson JE, Baker JR Jr, Wang SH.

Nanomedicine (Lond). 2017 May;12(10):1177-1185. doi: 10.2217/nnm-2017-0025. Epub 2017 Apr 27.

PMID:
28447896
31.

Improved High-Quality Draft Genome Sequence and Annotation of Burkholderia contaminans LMG 23361T.

Jung JY, Ahn Y, Kweon O, LiPuma JJ, Hussong D, Marasa BS, Cerniglia CE.

Genome Announc. 2017 Apr 20;5(16). pii: e00245-17. doi: 10.1128/genomeA.00245-17.

32.

Overcoming an Extremely Drug Resistant (XDR) Pathogen: Avibactam Restores Susceptibility to Ceftazidime for Burkholderia cepacia Complex Isolates from Cystic Fibrosis Patients.

Papp-Wallace KM, Becka SA, Zeiser ET, Ohuchi N, Mojica MF, Gatta JA, Falleni M, Tosi D, Borghi E, Winkler ML, Wilson BM, LiPuma JJ, Nukaga M, Bonomo RA.

ACS Infect Dis. 2017 Jul 14;3(7):502-511. doi: 10.1021/acsinfecdis.7b00020. Epub 2017 Mar 30.

33.

A Broad-Host-Range Tailocin from Burkholderia cenocepacia.

Yao GW, Duarte I, Le TT, Carmody L, LiPuma JJ, Young R, Gonzalez CF.

Appl Environ Microbiol. 2017 May 1;83(10). pii: e03414-16. doi: 10.1128/AEM.03414-16. Print 2017 May 15.

34.

An Outbreak of Burkholderia cepacia Complex Infections Associated with Contaminated Liquid Docusate.

Marquez L, Jones KN, Whaley EM, Koy TH, Revell PA, Taylor RS, Bernhardt MB, Wagner JL, Dunn JJ, LiPuma JJ, Campbell JR.

Infect Control Hosp Epidemiol. 2017 May;38(5):567-573. doi: 10.1017/ice.2017.11. Epub 2017 Feb 7.

PMID:
28166854
35.

Cystic Fibrosis Mice Develop Spontaneous Chronic Bordetella Airway Infections.

Darrah R, Bonfield T, LiPuma JJ, Litman P, Hodges CA, Jacono F, Drumm M.

J Infect Pulm Dis. 2017;3(2). doi: 10.16966/2470-3176.128. Epub 2017 Nov 2.

36.

Environmental Pseudomonads Inhibit Cystic Fibrosis Patient-Derived Pseudomonas aeruginosa.

Chatterjee P, Davis E, Yu F, James S, Wildschutte JH, Wiegmann DD, Sherman DH, McKay RM, LiPuma JJ, Wildschutte H.

Appl Environ Microbiol. 2016 Dec 30;83(2). pii: e02701-16. doi: 10.1128/AEM.02701-16. Print 2017 Jan 15.

37.

Intrinsic Resistance of Burkholderia cepacia Complex to Benzalkonium Chloride.

Ahn Y, Kim JM, Kweon O, Kim SJ, Jones RC, Woodling K, Gamboa da Costa G, LiPuma JJ, Hussong D, Marasa BS, Cerniglia CE.

MBio. 2016 Nov 22;7(6). pii: e01716-16. doi: 10.1128/mBio.01716-16.

38.

Exploring the Role of the Ω-Loop in the Evolution of Ceftazidime Resistance in the PenA β-Lactamase from Burkholderia multivorans, an Important Cystic Fibrosis Pathogen.

Papp-Wallace KM, Becka SA, Taracila MA, Zeiser ET, Gatta JA, LiPuma JJ, Bonomo RA.

Antimicrob Agents Chemother. 2017 Jan 24;61(2). pii: e01941-16. doi: 10.1128/AAC.01941-16. Print 2017 Feb.

39.

Complete Genome Sequences of Bordetella flabilis, Bordetella bronchialis, and "Bordetella pseudohinzii".

Spilker T, Darrah R, LiPuma JJ.

Genome Announc. 2016 Oct 13;4(5). pii: e01132-16. doi: 10.1128/genomeA.01132-16.

40.

Complete Genome Sequences of 17 Rapidly Growing Nontuberculous Mycobacterial Strains.

Caverly LJ, Spilker T, LiPuma JJ.

Genome Announc. 2016 Sep 22;4(5). pii: e01009-16. doi: 10.1128/genomeA.01009-16.

41.

The Effects of Signal Erosion and Core Genome Reduction on the Identification of Diagnostic Markers.

Sahl JW, Vazquez AJ, Hall CM, Busch JD, Tuanyok A, Mayo M, Schupp JM, Lummis M, Pearson T, Shippy K, Colman RE, Allender CJ, Theobald V, Sarovich DS, Price EP, Hutcheson A, Korlach J, LiPuma JJ, Ladner J, Lovett S, Koroleva G, Palacios G, Limmathurotsakul D, Wuthiekanun V, Wongsuwan G, Currie BJ, Keim P, Wagner DM.

MBio. 2016 Sep 20;7(5). pii: e00846-16. doi: 10.1128/mBio.00846-16.

42.
43.

Taxonomic dissection of Achromobacter denitrificans Coenye et al. 2003 and proposal of Achromobacter agilis sp. nov., nom. rev., Achromobacter pestifer sp. nov., nom. rev., Achromobacter kerstersii sp. nov. and Achromobacter deleyi sp. nov.

Vandamme PA, Peeters C, Inganäs E, Cnockaert M, Houf K, Spilker T, Moore ER, LiPuma JJ.

Int J Syst Evol Microbiol. 2016 Sep;66(9):3708-3717. doi: 10.1099/ijsem.0.001254. Epub 2016 Jun 30.

PMID:
27373279
44.

Complete Genome Sequence of Mycobacterium abscessus subsp. bolletii.

Caverly LJ, Spilker T, LiPuma JJ.

Genome Announc. 2016 Jun 9;4(3). pii: e00543-16. doi: 10.1128/genomeA.00543-16.

45.

Episodic oral antibiotic use in CF: Discordance between the electronic medical record and self-report.

Caverly LJ, Caverly TJ, Kalikin LM, Foster BK, Simon RH, LiPuma JJ.

J Cyst Fibros. 2016 Sep;15(5):630-3. doi: 10.1016/j.jcf.2016.04.009. Epub 2016 May 5.

46.

Draft Genome Sequences of 63 Pseudomonas aeruginosa Isolates Recovered from Cystic Fibrosis Sputum.

Spilker T, LiPuma JJ.

Genome Announc. 2016 Apr 21;4(2). pii: e00231-16. doi: 10.1128/genomeA.00231-16.

47.

Culture-Independent Identification of Nontuberculous Mycobacteria in Cystic Fibrosis Respiratory Samples.

Caverly LJ, Carmody LA, Haig SJ, Kotlarz N, Kalikin LM, Raskin L, LiPuma JJ.

PLoS One. 2016 Apr 19;11(4):e0153876. doi: 10.1371/journal.pone.0153876. eCollection 2016.

48.

Complete Genome Sequence of emm28 Type Streptococcus pyogenes MEW123, a Streptomycin-Resistant Derivative of a Clinical Throat Isolate Suitable for Investigation of Pathogenesis.

Jacob KM, Spilker T, LiPuma JJ, Dawid SR, Watson ME Jr.

Genome Announc. 2016 Mar 17;4(2). pii: e00136-16. doi: 10.1128/genomeA.00136-16.

49.
50.

The Microbiome in Cystic Fibrosis.

Huang YJ, LiPuma JJ.

Clin Chest Med. 2016 Mar;37(1):59-67. doi: 10.1016/j.ccm.2015.10.003. Epub 2015 Dec 23. Review.

Supplemental Content

Loading ...
Support Center